Literature DB >> 6269682

Binding of [3H]-prazosin and [3H]-dihydroergocryptine to rat cardiac alpha-adrenoceptors.

P Guicheney, P Meyer.   

Abstract

1 [3H]-prazosin binds specifically to a single class of alpha-adrenoceptors in rat cardiac membranes (KD25 degrees C = 0.2 nM). 2 That these receptors are of the alpha 1-type was indicated by competition studies, i.e. alpha 1-antagonists such as prazosin and (2-(2,6-dimethoxyphenoxyethyl) aminomethyl-1, 4-benzodioxane (WB 4101) were more potent than the alpha 2-antagonists, yohimbine and piperoxan in inhibiting [3H]-prazosin binding. 3 A comparative study of [3H]-prazosin binding and [3H]-dihydroergocryptine binding to cardiac membranes showed that both [3H]-prazosin and [3H]-dihydroergocryptine (at low concentrations) bind to alpha 2-adrenoceptors, while [3H]-dihydroergocryptine (at higher concentrations) also binds to another class of sites.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269682      PMCID: PMC2071842          DOI: 10.1111/j.1476-5381.1981.tb16768.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors.

Authors:  D C U'Prichard; D A Greenberg; S H Snyder
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

2.  Biochemical and mechanical effects of phenylephrine on the heart.

Authors:  S C Verma; J H McNeill
Journal:  Eur J Pharmacol       Date:  1976-04       Impact factor: 4.432

3.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 4.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

5.  Influence of extracellular noradrenaline on the stimulation-evoked secretion of noradrenaline from sympathetic nerves: evidence for an -receptor-mediated feed-back inhibition of noradrenaline release.

Authors:  K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Alpha sympathomimetic inhibition of adrenergic and cholinergic transmission in the rabbit heart.

Authors:  K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding.

Authors:  L T Williams; D Mullikin; R J Lefkowitz
Journal:  J Biol Chem       Date:  1976-11-25       Impact factor: 5.157

9.  Ontogeny of beta-adrenergic receptors in rat cerebral cortex.

Authors:  T K Harden; B B Wolfe; J R Sporn; J P Perkins; P B Molinoff
Journal:  Brain Res       Date:  1977-04-08       Impact factor: 3.252

10.  Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha- and beta-receptors.

Authors:  N Yamaguchi; J de Champlain; R A Nadeau
Journal:  Circ Res       Date:  1977-07       Impact factor: 17.367

View more
  3 in total

Review 1.  [Alpha-adrenoceptors in the myocardium: incidence and functional significance].

Authors:  A Mügge
Journal:  Klin Wochenschr       Date:  1985-11-04

2.  Alpha 1-adrenoceptor function and autoradiographic distribution in human asthmatic lung.

Authors:  D Spina; P J Rigby; J W Paterson; R G Goldie
Journal:  Br J Pharmacol       Date:  1989-07       Impact factor: 8.739

3.  The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; Lise R Moltzau; Silje V S Bekkevold; Dagny L Sandnes; Jon Arne K Birkeland; Tor Skomedal; Jan-Bjørn Osnes; Ivar Sjaastad; Finn Olav Levy
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.